LONG COVID-19 AND QUALITY OF LIFE: A SYSTEMATIC REVIEW
Keywords:
Cognitive Impariment, Covid-19, Long-Covid, Lung Fibrosis, Quality of lifeAbstract
The majority of patients receiving Covid-19 report experiencing effects ranging from mild to severe. Ten percent to fifteen percent of patients develop severe symptoms, and five percent of cases progress to a critical stage. In many patients, particular symptoms may persist for several weeks or months after recovery has taken place. Also a possibility in more benign circumstances. During this stage of the process, the patient is no longer infectious. Patients experienced a wide range of different outcomes after Covid-19. Long covid syndrome is characterized by the persistence of clinical symptoms in Covid-19 patients for 4 to 12 weeks after the initial onset, or for 12 weeks or more, which is known as chronic post-covid syndrome, according to the World Health Organization (WHO) in the year 2020. Long- Covid syndrome is also known as post-covid syndrome. This drawn- out process of covid production results in symptoms such as fatigue, headache, shortness of breath, anosmia, muscle weakness, and cognitive impairment. Patients who have long- Covid suffer from a multitude of difficulties, including those related to the heart, the respiratory system, cognitive function, and so on. After pulmonary disorders, cognitive disorders are the most frequent type of illness. Patients diagnosed with both conditions frequently report having a lower quality of life due to the effects of long-Covid.
References
Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID19) current status and future perspectives: A narrative review. Vol. 17, International Journal of Environmental Research and Public Health. MDPI AG; 2020.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. J Penyakit Dalam Indones. April 2020;7(1):45.
Iqbal A, Iqbal K, Arshad Ali S, Azim D, Farid E, Baig MD, et al. The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors. Cureus. Februari 2021;13(2):e13080.
Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms underlying disease severity and progression. Physiology. 2020;35(5):288–301.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post- acute covid-19 in primary care. BMJ. Agustus 2020;370:m3026.
World Health Organization’s (WHO). Coronavirus disease (COVID-19): Post COVID-19 condition [Internet] Coronavirus disease (COVID-19): Post COVID- 19 condition. 2021. Tersedia pada: https://www.who.int/newsroom/questions- and-answers/item/coronavirus-disease-(covid-19)-post-covid-19- condition#:~:text=While most people who develop,of mental focus and clarity).
Carfì A, Bernabei R, Landi F, Group for the GAC-19 P-ACS. Persistent Symptoms in Patients After Acute
COVID-19. JAMA [Internet] 11 Agustus 2020;324(6):603–5. Tersedia pada: https://doi.org/10.1001/jama.2020.12603
Gorna R, MacDermott N, Rayner C, O’Hara M, Evans S, Agyen L, et al. Long COVID guidelines need to reflect lived experience. Lancet (London, England). Februari 2021;397(10273):455–7.
Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health Qual Life Outcomes [Internet] 2022;20(1):125. Tersedia pada: https://doi.org/10.1186/s12955-022-02033-6
Chen K-Y, Li T, Gong F-H, Zhang J-S, Li X-K. Predictors of health-related quality of life and influencing factors for COVID-19 patients, a follow-up at one month. Front Psychiatry. 2020;11:668.
Carenzo L, Protti A, Dalla Corte F, Aceto R, Iapichino G, Milani A, et al. Short- term health-related quality of life, physical function and psychological consequences of severe COVID-19. Ann Intensive Care. 2021;11(1):1–8.
Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong public Heal Res Perspect. 2020;11(5):296.
Líška D, Liptaková E, Babičová A, Batalik L, Baňárová PS, Dobrodenková S. What is the quality of life in patients with long COVID compared to a healthy control group? [Internet] Vol. 10, Frontiers in Public Health . 2022. Tersedia pada: https://www.frontiersin.org/articles/10.3389/fpubh.2022.975992
de Oliveira JF, de Ávila RE, de Oliveira NR, da Cunha Severino Sampaio N, Botelho M, Gonçalves FA, et al. Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil. Int J Infect Dis [Internet] 2022;122:1044–51. Tersedia pada: https://www.sciencedirect.com/science/article/pii/S1201971222004581
Burhan E, Susanti AD, Isbaniah F, Nasution SA, Ginanjar E, Pitoyo CW, et al. Pedoman Tatalaksana COVID-19. 4 ed. Burhan E, Susanti AD, Isbaniah F, Nasution SA, Ginanjar E, Pitoyo CW, et al., editor. Jakarta:
Perhimpunan Dokter Paru Indonesia (PDPI); Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI); Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI); Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN); Ikatan Dokte; 2022.
Vehar S, Boushra M, Ntiamoah P, Biehl M. Post-acute sequelae of SARS-CoV-2 infection: Caring for the “longhaulers”. Cleve Clin J Med. Mei 2021;88(5):267– 72.
Yong SJ. Long-Haul COVID-19: Putative Pathophysiology, Risk Factors, and Treatments. Preprint. 2020;
Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An Overview and Approach to Classification. Open forum Infect Dis. Desember 2020;7(12):ofaa509.
Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. Kuwano K, editor. Pulm Med [Internet] 2020;2020:6175964. Tersedia pada: https://doi.org/10.1155/2020/6175964
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428–42.
Daines L, Zheng B, Pfeffer P, Hurst JR, Sheikh A. A clinical review of long- COVID with a focus on the respiratory system. Curr Opin Pulm Med. 2022;28(3):174–9.
Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Physiol. 2022;322(1):C1–11.
Zhou J, Tan J. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China. Vol. 107, Metabolism: clinical and experimental.United States; 2020. hal. 154216.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
